Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Emory University
Emory University
Hospital Universitario de Móstoles
State Scientific Centre of Coloproctology, Russian Federation
Egymedicalpedia
Columbia University
Istanbul Medipol University Hospital
Hospital Provincial de Castellon
Parc de Salut Mar
Washington University School of Medicine
Saneso Inc.
Instituto Ecuatoriano de Enfermedades Digestivas
American College of Radiology Imaging Network
Indiana University
University of Pennsylvania
Military University Hospital, Prague
GI View Ltd.
Technical University of Munich
PeerMedical Ltd.
McMaster University